The Centre will promote the translation of these discoveries into clinical and commercial applications by providing the infrastructure required for new academic-industrial partnerships. This will have both immediate and long-term benefits for human health and the UK economy.
The Centre will house:
- a dedicated 'Incubator' space, where research scientists from industrial partners and start-up companies will occupy laboratory and desk space alongside academic researchers
- the Centre for Protein Misfolding Disease, which aims to effect a step-change in basic and translational research on molecular approaches to combat modern pandemics such as Alzheimer’s and Parkinson’s diseases and type II diabetes
- the Molecular Production and Characterisation Centre, which will provide support and access to state-of-the-art instrumentation for in-house, UK-wide academic and industrial users in the chemistry of health area.